We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

58 hedge funds and large institutions have $154M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

5% more capital invested

Capital invested by funds: $146M → $154M (+$7.48M)

4% more funds holding

Funds holding: 56 → 58 (+2)

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
8
Closed
6
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$6.55M
2
SCM
Saba Capital Management
New York
+$6.01M
3
UOC
UBS O'Connor
Illinois
+$4.2M
4
FTCM
First Trust Capital Management
Illinois
+$3.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.75M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.55M
2
Citadel Advisors
Citadel Advisors
Florida
-$6M
3
BCM
Beryl Capital Management
California
-$5.65M
4
MI
MMCAP International
Cayman Islands
-$5M
5
SC
Sculptor Capital
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$21.7M +$6.01M +601,000 +38%
HCM
2
Highbridge Capital Management
New York
$9.59M +$595K +59,514 +7%
SC
3
Sculptor Capital
New York
$8.6M -$1.42M -141,824 -14%
PC
4
Periscope Capital
Ontario, Canada
$8.05M +$1.02M +101,800 +14%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$7.87M +$2.75M +275,132 +54%
HSBC Holdings
6
HSBC Holdings
United Kingdom
$6.54M +$6.55M +655,068 New
Marshall Wace
7
Marshall Wace
United Kingdom
$5.29M +$22.5K +2,250 +0.4%
MI
8
MMCAP International
Cayman Islands
$5.01M -$5M -500,000 -50%
PAMP
9
Polar Asset Management Partners
Ontario, Canada
$5.01M – – –
AA
10
AQR Arbitrage
Connecticut
$4.56M +$1.69M +169,000 +59%
CSS
11
Cubist Systematic Strategies
Connecticut
$4.4M +$123K +12,288 +3%
UOC
12
UBS O'Connor
Illinois
$4.21M +$4.2M +420,018 New
AC
13
Aristeia Capital
Connecticut
$4.2M +$1.69M +169,000 +68%
WRBC
14
W.R. Berkley Corp
Connecticut
$4.07M – – –
CF
15
Cantor Fitzgerald
New York
$4.01M – – –
SCM
16
Shaolin Capital Management
Florida
$4.01M +$1.03M +102,826 +35%
FTCM
17
First Trust Capital Management
Illinois
$3.21M +$3.2M +320,072 New
RCM
18
Radcliffe Capital Management
Pennsylvania
$3.01M – – –
FTCM
19
Fir Tree Capital Management
New York
$2.97M -$8.91K -891 -0.3%
Millennium Management
20
Millennium Management
New York
$2.65M +$2.64M +264,160 New
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$2.5M – – –
TCM
22
Tenor Capital Management
New York
$2.5M – – –
KL
23
KIM LLC
Kansas
$2.5M +$2.5M +250,000 New
WAM
24
Weiss Asset Management
Massachusetts
$2.42M – – –
Goldman Sachs
25
Goldman Sachs
New York
$2.02M – – –
1
2 3

IQMD Hedge Fund Activity: Q2 2022 in Review

58 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2022, worth a combined $154M — up 5.1% from $146M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IQMD positions and 6 closed out — a net gain of 2 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.55M. The largest seller was Linden Advisors, cutting an estimated $6.55M.

  • 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2022, up from 56 in Q1 2022.
  • Funds reported $154M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2022, up 5.1% quarter-over-quarter.
  • 8 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2022 and 6 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q2 2022 was HSBC Holdings, an estimated $6.55M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2022 was Linden Advisors, an estimated $6.55M sold.

Based on aggregated 13F filings for Q2 2022.